Dr Reddys launches OTC store-brand equivalent of Allegra-D 24 HR in US market

26 Jul 2022 , 01:33 AM

Dr Reddys Laboratories announced the first-to-market launch of over-the-counter OTC Fexofenadine HCl 180 mg and Pseudoephedrine HCl 240 mg Extended Release Tablets USP the store-brand equivalent of Allegra-D 24 HR in the US market as approved by the US Food and Drug Administration USFDA Dr Reddys OTC Fexofenadine HCl 180 mg and Pseudoephedrine HCl 240 mg Extended Release Tablets USP is an over-the-counter oral antihistamine and nasal decongestant for the temporary relief of nasal and sinus congestion due to colds or allergies It temporarily relieves sneezing; runny nose; itchy watery eyes; and itchy nose or throat due to allergies Allegra-D 24 HR had US retail sales of approximately $45 million as of May 2022 according to IRI